Histone Deacetylase Inhibitors Downregulate CCR4 Expression and Decrease Mogamulizumab Efficacy in CCR4-Positive Mature T-Cell Lymphomas

被引：0
|
作者：
Kitadate, Akihiro
Ikeda, Sho
Abe, Fumito
Takahashi, Naoto
Shimizu, Norio
Matsue, Kosei
Tagawa, Hiroyuki
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
720
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Histone deacetylase inhibitors downregulate CCR4 expression and decrease mogamulizumab efficacy in CCR4-positive mature T-cell lymphomas
    Kitadate, Akihiro
    Ikeda, Sho
    Abe, Fumito
    Takahashi, Naoto
    Shimizu, Norio
    Matsue, Kosei
    Tagawa, Hiroyuki
    HAEMATOLOGICA, 2018, 103 (01) : 126 - 135
  • [2] Mogamulizumab and the treatment of CCR4-positive T-cell lymphomas
    Remer, Marcus
    Al-Shamkhani, Aymen
    Glennie, Martin
    Johnson, Peter
    IMMUNOTHERAPY, 2014, 6 (11) : 1187 - 1206
  • [3] HDAC inhibitors decrease mogamulizumab efficacy with downregulation of CCR4 in T-cell lymphoma
    Kitadate, Akihiro
    Ikeda, Sho
    Abe, Fumito
    Teshima, Kazuaki
    Takahashi, Naoto
    Matsue, Kosei
    Tagawa, Hiroyuki
    CANCER SCIENCE, 2018, 109 : 506 - 506
  • [4] Immunohistochemistry for CCR4C-terminus predicts CCR4 mutations and mogamulizumab efficacy in adult T-cell leukemia/lymphoma
    Fujii, Keiichiro
    Sakamoto, Yuma
    Masaki, Ayako
    Murase, Takayuki
    Tashiro, Yukie
    Yonekura, Kentaro
    Utsunomiya, Atae
    Ito, Asahi
    Kusumoto, Shigeru
    Iida, Shinsuke
    Ueda, Ryuzo
    Ishida, Takashi
    Inagaki, Hiroshi
    JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2021, 7 (01): : 52 - 60
  • [5] Resistance to mogamulizumab is associated with loss of CCR4 in cutaneous T-cell lymphoma
    Beygi, Sara
    Duran, George E.
    Fernandez-Pol, Sebastian
    Rook, Alain H.
    Kim, Youn H.
    Khodadoust, Michael S.
    BLOOD, 2022, 139 (26) : 3732 - 3736
  • [6] Expression of CCR4 in adult T-cell leukemia
    Yoshie, O
    LEUKEMIA & LYMPHOMA, 2005, 46 (02) : 185 - 190
  • [7] A phase 2 trial of CHOP with anti-CCR4 antibody mogamulizumab for elderly patients with CCR4-positive adult T-cell leukemia/lymphoma.
    Choi, Ilseung
    Yoshimitsu, Makoto
    Kusumoto, Shigeru
    Shimokawa, Mototsugu
    Utsunomiya, Atae
    Suehiro, Youko
    Hidaka, Tomonori
    Nosaka, Kisato
    Sasaki, Hidenori
    Rai, Shinya
    Tamura, Shinobu
    Owatari, Satsuki
    Koh, Ki-Ryang
    Nakamura, Daisuke
    Tokunaga, Masahito
    Sekine, Masaaki
    Sakamoto, Yuma
    Inagaki, Hiroshi
    Ishida, Takashi
    Ishitsuka, Kenji
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] Resistance to Mogamulizumab Is Associated with Loss of CCR4 in Cutaneous T Cell Lymphoma
    Beygi, Sara
    Fernandez-Pol, Sebastian
    Duran, George
    Kim, Youn H.
    Khodadoust, Michael S.
    BLOOD, 2021, 138
  • [9] Current State and Therapeutic Potential of CCR4 Therapies in Cutaneous T-Cell Lymphomas
    Zengarini, C.
    Filippini, A.
    Guglielmo, A.
    Morsia, E.
    Mussi, M.
    Vocale, L.
    Piraccini, B. M.
    Pileri, A.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S68 - S69
  • [10] Loss of CCR4 antigen expression after mogamulizumab therapy in a case of adult T-cell leukaemia-lymphoma
    Ohno, Nobuhiro
    Kobayashi, Seiichiro
    Ishigaki, Tomohiro
    Yuji, Koichiro
    Kobayashi, Masayuki
    Sato, Koota
    Watanabe, Nobukazu
    Tojo, Arinobu
    Uchimaru, Kaoru
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 163 (05) : 683 - 685
12345